In fresh primary tumors, the Mapk10 promoter was frequently methylated in 12/18 (66%) HCC tissues, while reduced or no methylation was detected in the adjacent non-tumor tissues (Fig. 4A), suggesting that the methylation of Mapk10 is tumor-specific. The gene discussed is MAPK10; the disease is hepatocellular carcinoma.